• <samp id="ossg8"></samp>
    <tbody id="ossg8"><nobr id="ossg8"></nobr></tbody>
    <menuitem id="ossg8"><strong id="ossg8"></strong></menuitem>
    • <samp id="ossg8"></samp>
    <menuitem id="ossg8"><strong id="ossg8"></strong></menuitem>
  • <menuitem id="ossg8"><ins id="ossg8"></ins></menuitem>

    • <tbody id="ossg8"><nobr id="ossg8"></nobr></tbody>
    <menuitem id="ossg8"></menuitem>
        Skip directly to search Skip directly to A to Z list Skip directly to site content
        CDC Home

        Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. Type 508 Accommodation and the title of the report in the subject line of e-mail.

        Appendix A: Conflicts of Interest

        External Work Group Members

        Miriam Alter, PhD

        For the work under consideration:

        No financial conflict of interest reported

        Other relevant financial activities:

        No financial conflict of interest reported

        Sanjeev Arora, MD

        For the work under consideration:

        No financial conflict of interest reported

        Other relevant financial activities:

        Consultancy:

        Served on Advisory Board of Vertex Pharmaceuticals in 2009

        Grants/Grants Pending:

        Grants from Vertex Pharmaceuticals, Roche/ Genentech, Gilead, Zyrnogenetics, Bristol Myers, Pharmasett, and Abbott paid to institution for clinical trials

        Lectures/ Speakers Bureaus:

        Scherring Corp., served on September Bureau for Roche Pharmaceuticals until mid-2009

        Bruce Bacon, MD

        For the work under consideration:

        No financial conflict of interest reported

        Other relevant financial activities:

        No financial conflict of interest reported

        Doug Campos-Outcalt, MD

        For the work under consideration:

        No financial conflict of interest reported

        Other relevant financial activities:

        No financial conflict of interest reported

        Alfred DeMaria, Jr., MD

        For the work under consideration:

        No financial conflict of interest reported

        Other relevant financial activities:

        No financial conflict of interest reported

        Janet Durfee, MSN

        For the work under consideration:

        No financial conflict of interest reported

        Other relevant financial activities:

        No financial conflict of interest reported

        Yngve Falck-Ytter, MD

        For the work under consideration:

        No financial conflict of interest reported

        Other relevant financial activities:

        No financial conflict of interest reported

        Colleen Flanigan, MS

        For the work under consideration:

        Support for Travel:

        CDC Foundation

        Other relevant financial activities:

        No financial conflict of interest reported

        Marc Ghany, MD

        For the work under consideration:

        No financial conflict of interest reported

        Other relevant financial activities:

        No financial conflict of interest reported

        Robert Gish, MD

        For the work under consideration:

        No financial conflict of interest reported

        Other relevant financial activities:

        Board Membership:

        Hepahope

        Consultancy:

        Performed as a consultant to Abbott, Anadys Pharmaceuticals, Inc., Bayer AG, Bristol-Myers Squibb Company, Durect, Hepahope, Hoffman-LaRoche Ltd., Genentech, Gilead Sciences, GlaxoSmithKline, GlobeImmune, Human Genome Sciences, Merck, Metabasis Therapeutics, OSI/Astellas Parmasset, Schering-Plough Corporation, Three Rivers Pharma, VitalTherapies, and ZymoGenetics; payments directed to an SPF fund for research and education.

        Lectures/ Speakers Bureaus:

        Speakers bureau activities for Bayer, Bristol-Myers Squibb Company, F. Hoffman-LaRoche Ltd., Gilead Sciences, Inc., GlaxoSmithKline, Onyx, Merck/Schering-Plough Corporation, Three Rivers, Salix, SciClone Pharmaceuticals focused on HBV, HCV, and liver cancer, specifically epidemiology, diagnosis, and treatment, with additional program presentations for HBV and management of complications of cirrhosis; has a speakers contract to do promotional talks for BMS, Roche, Schering-Plough, Gilead Sciences, Bayer and Onyx; payments are directed to an SPF fund for research and education.

        Grants/ Grants Pending:

        Support from Bayer-Onyx, Bristol-Myers Squibb Company, Genentech/ F. Hoffman-LaRoche, Ltd., Gilead Sciences, Genentech, Pharmasset, Zymogenetics; payments directed to an institutional fund under contract to CPMC.

        Stock/ Stock Options:

        Major stock shareholder for Hepahope

        Fasiha Kanwal, MD

        For the work under consideration:

        No financial conflict of interest reported

        Other relevant financial activities:

        No financial conflict of interest reported

        Emmett Keeffe, MD

        For the work under consideration:

        No financial conflict of interest reported

        Other relevant financial activities:

        Consultancy:

        Vertex

        Travel/ Accommodations:

        Vertex

        Kathleen Koechlin, PhD

        For the work under consideration:

        No financial conflict of interest reported

        Other relevant financial activities:

        No financial conflict of interest reported

        Cameron Lewis

        For the work under consideration:

        No financial conflict of interest reported

        Other relevant financial activities:

        No financial conflict of interest reported

        Jake Liang, MD

        For the work under consideration:

        No financial conflict of interest reported

        Other relevant financial activities:

        No financial conflict of interest reported

        Robert Lubran, MPA

        For the work under consideration:

        No financial conflict of interest reported

        Other relevant financial activities:

        No financial conflict of interest reported

        Iris Mabry-Hernandez, MD

        For the work under consideration:

        No financial conflict of interest reported

        Other relevant financial activities:

        No financial conflict of interest reported

        Katherine McGlynn, PhD

        For the work under consideration:

        No financial conflict of interest reported

        Other relevant financial activities:

        No financial conflict of interest reported

        Barbara McGovern, MD

        For the work under consideration:

        No financial conflict of interest reported

        Other relevant financial activities:

        Employment:

        Editor at UpToDate

        Other:

        Editor at Infectious Diseases Society of America

        Rachel McLean, MPH

        For the work under consideration:

        No financial conflict of interest reported

        Other relevant financial activities:

        No financial conflict of interest reported

        Michael Ninburg

        For the work under consideration:

        No financial conflict of interest reported

        Other relevant financial activities:

        Consultancy:

        Vertex, Abbott, Genentech, GlaxoSmithKline, Merck, Hoffman LaRoche, Tibotec, Boehringer Ingelheim

        Grants/ Grants Pending:

        Grants from Vertex, Merck, Genentech, Hoffman La Roche, Schering Plough, Gilead, Novartis, and Human Genome Sciences paid to institution

        Payment for the Development of Educational Presentations:

        Vertex, Hoffmann La Roche, and Schering Plough, paid to institution

        Phillip Reichert, MPH

        For the work under consideration:

        No financial conflict of interest reported

        Other relevant financial activities:

        No financial conflict of interest reported

        Vinod Rustgi, MD

        For the work under consideration:

        No financial conflict of interest reported

        Other relevant financial activities:

        Consultancy:

        Merck, Vertex

        Grants/ Grants Pending:

        Grants from BMS, Gilead, Anadys, Boehringer-Ingelheim-Abbott paid to institution

        Lectures/ Speakers Bureaus:

        Merck, Vertex, Genentech, Gilead, Onyx

        Lorren Sandt

        For the work under consideration:

        No financial conflict of interest reported

        Other relevant financial activities:

        Consultancy:

        Abbott, for community advisory board and paid to institution

        Grants/ Grants Pending:

        Unrestricted educational grants from Vertex, Merck, and Genentech paid to institution; Conference grant from Gilead paid to institution

        Travel/ Accommodations:

        Money for travel from BMS, Vertex, Boehringer Ingelheim, Merck, Genentech/Roche and Tibotec for community advisory boards and paid to institution

        Gloria Searson

        For the work under consideration:

        No financial conflict of interest reported

        Other relevant financial activities:

        No financial conflict of interest reported

        Anne Spaulding, MD

        For the work under consideration:

        No financial conflict of interest reported

        Other relevant financial activities:

        Consultancy:

        Georgia Correctional Healthcare; clinical consultant for hepatitis and HIV care

        Grants/ Grants Pending:

        Grant support from DHHS, CDC, HRSA, and indirectly from NIH paid to institution

        Lectures/ Speakers Bureaus:

        Hepatitis Foundation International, Albany Medical College

        Donna Sweet, MD

        For the work under consideration:

        No financial conflict of interest reported

        Other relevant financial activities:

        Grants/ Grants Pending:

        Pfizer, BMS Pharmaceuticals

        Lectures/ Speakers Bureaus:

        Abbott, BMS, Boehringer Ingelheim, Tibotec, Gilead

        Andrew Talal, MD

        For the work under consideration:

        No financial conflict of interest reported

        Other relevant financial activities:

        Board Membership:

        Merck & Co., Genentech/Roche, Boehringer Ingelheim, Pfizer, Bayer/ Onyx, Vertex

        Consultancy:

        Merck & Co., Genentech

        Grants/ Grants Pending:

        Merck & Co., Vertex, Boehringer-Ingelheim, and Genentech/Roche, Pfizer, Bayer/Onyx paid to institution

        Lectures/ Speakers Bureaus:

        Vertex and Genentech/ Roche

        Payment for Development of Educational Presentations:

        Merck & Co., Medscape

        Litjen Tan, PhD

        For the work under consideration:

        No financial conflict of interest reported

        Other relevant financial activities:

        No financial conflict of interest reported

        Chris Taylor

        For the work under consideration:

        No financial conflict of interest reported

        Other relevant financial activities:

        Grants/ Grants Pending:

        Vertex, Gilead, OraSure, Merck & Co., Janssen, BMS paid to institution

        Travel/ Accommodations:

        Vertex, OraSure

        Lisa Townshend-Bulson, MSN

        For the work under consideration:

        No financial conflict of interest reported

        Other relevant financial activities:

        Expert Testimony:

        CDC Cooperative Agreement with ANTHC, paid to institution

        Tam Van

        For the work under consideration:

        No financial conflict of interest reported

        Other relevant financial activities:

        No financial conflict of interest reported

        Kathleen Whitaker, PhD

        For the work under consideration:

        No financial conflict of interest reported

        Other relevant financial activities:

        No financial conflict of interest reported

        Richard Wild, MD

        For the work under consideration:

        No financial conflict of interest reported

        Other relevant financial activities:

        No financial conflict of interest reported

        John Wong, MD

        For the work under consideration:

        No financial conflict of interest reported

        Other relevant financial activities:

        No financial conflict of interest reported

        CDC Work Group Members

        Geoff Beckett, MPH

        For the work under consideration:

        No financial conflict of interest reported

        Other relevant financial activities:

        No financial conflict of interest reported

        Scott Holmberg, MD

        For the work under consideration:

        No financial conflict of interest reported

        Other relevant financial activities:

        No financial conflict of interest reported

        Deborah Holtzman, PhD

        For the work under consideration:

        No financial conflict of interest reported

        Other relevant financial activities:

        No financial conflict of interest reported

        Rebecca Morgan, MPH

        For the work under consideration:

        No financial conflict of interest reported

        Other relevant financial activities:

        No financial conflict of interest reported

        Dan Riedford, JD

        For the work under consideration:

        No financial conflict of interest reported

        Other relevant financial activities:

        No financial conflict of interest reported

        Bryce Smith, PhD

        For the work under consideration:

        No financial conflict of interest reported

        Other relevant financial activities:

        No financial conflict of interest reported

        Philip Spradling, MD

        For the work under cocnsideration:

        No financial conflict of interest reported

        Other relevant financial activities:

        No financial conflict of interest reported

        Chong-Gee Teo, MD

        For the work under consideration:

        No financial conflict of interest reported

        Other relevant financial activities:

        No financial conflict of interest reported

        John W. Ward, MD

        For the work under consideration:

        No financial conflict of interest reported

        Other relevant financial activities:

        No financial conflict of interest reported


        Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services.

        References to non-CDC sites on the Internet are provided as a service to MMWR readers and do not constitute or imply endorsement of these organizations or their programs by CDC or the U.S. Department of Health and Human Services. CDC is not responsible for the content of pages found at these sites. URL addresses listed in MMWR were current as of the date of publication.

        All MMWR HTML versions of articles are electronic conversions from typeset documents. This conversion might result in character translation or format errors in the HTML version. Users are referred to the electronic PDF version (http://www.cy118119.com/mmwr) and/or the original MMWR paper copy for printable versions of official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices.

        **Questions or messages regarding errors in formatting should be addressed to mmwrq@cdc.gov.

         
        USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
        Centers for Disease Control and Prevention   1600 Clifton Road Atlanta, GA 30329-4027, USA
        800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO
        A-Z Index
        1. A
        2. B
        3. C
        4. D
        5. E
        6. F
        7. G
        8. H
        9. I
        10. J
        11. K
        12. L
        13. M
        14. N
        15. O
        16. P
        17. Q
        18. R
        19. S
        20. T
        21. U
        22. V
        23. W
        24. X
        25. Y
        26. Z
        27. #
        国产精品久久久久久一级毛片